Clinical trial
Personalized Medicine in HCV Chronic Infection. Endothelial Dysfunction and Subclinical Atheromatosis in Patients With HCV Infection. Characterization and Potential Reversibility With Direct Antiviral Agents.
NCT02802280 is registered in ClinicalTrials.gov with Instituto de Investigación Marqués de Valdecilla as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Medicine in HCV Chronic Infection. Endothelial Dysfunction and Subclinical Atheromatosis in Patients With HCV Infection. Characterization and Potential Reversibility With Direct Antiviral Agents.
- Lead sponsor
- Instituto de Investigación Marqués de Valdecilla
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 31, 2015
- Completion date
- March 31, 2017
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.